In a push for value-based care, UnitedHealth is pledging to double its provider payment in relation to quality and cost efficiency by up to $50 billion within the next 5 years.
In a push for value-based care, UnitedHealth is pledging to double its provider payment in relation to quality and cost efficiency by up to $50 billion within the next 5 years. Sam Ho, UnitedHealth's chief clinical officer, said this initiative was a large step for the organization. However, it is seen as a necessary step in moving forward for healthcare reform. Fierce Health Payer reports:
Putting its money where its mouth is, UnitedHealth is promising to more than double its provider payments--to $50 billion--tied to quality and cost efficiency measures within the next five years, the company announced Wednesday.
UnitedHealth currently spends $20 billion on such accountable care provider contracts, which already have slowed the increase of medical costs and dropped emergency room visits by 17 percent.
With this decision, the country's largest health insurer will likely be accelerating efforts among insurers to move away from fee-for-service payments toward a value-based model, particularly because of its size and existing accountable care contracts, Forbes reported.
Read the full story here: http://bit.ly/1dzPaon
Humana Report Shows Benefits of Value-Based Care for Patients, Physicians
December 6th 2023Patients seen at value-based care clinics received more preventive screenings and had lower risks of hospitalization and emergency room visits, according to Humana’s 10th annual value-based care report.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Data analysis showed that 40% of patients who filled a prescription for Wegovy in 2021 or 2022 were still taking it a year later; both Democrats and reproductive rights organizations are pressuring the Biden administration to ensure health insurers fully cover contraception; CMS implemented Medicare changes in March that limited access to blood tests that help transplant recipients ensure their organs remain healthy.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen